A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5950 participants.
Also called NCT06627322
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 5,950 participants
- Sponsor
- Registry
-
NCT06627322
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06627322. Randomized; no masking; primary purpose prevention. Start 2024-11-21 (actual); primary completion 2029-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
- Acronym
- REMATCH
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Dual-combination therapy
- Intervention (Drug)
- Triple-combination therapy
- Intervention (Device)
- Dexcom G7, Pasta
- Lead sponsor
- Kyu Chang Won
- Collaborator
- Boryung Pharmaceutical Co., Ltd
- Collaborator
- Dong-A ST Co., Ltd.
- Collaborator
- HK inno.N Corporation
- Collaborator
- Daewoong Pharmaceutical Co. LTD.
- Collaborator
- Chong Kun Dang Pharmaceutical Corp.
- Collaborator
- Celltrion
- Collaborator
- Kakao Healthcare Corp.
- Collaborator
- Handok Inc.
Record details
- Record id
cardio:ct-nct06627322- Content hash
069df49621bc98cb09f138451cc0976e8f2c14ab07051af82682cdcf92a109ff